Mitochondrion of myocardial cell

The mitochondrion of myocardial cell refers to the population of mitochondria specifically present within cardiac muscle cells (cardiomyocytes). These mitochondria are highly specialized and densely packed, fulfilling the myocardium's immense energy demands by producing over 95% of cellular ATP through oxidative phosphorylation[3][4]. Myocardial mitochondria also regulate calcium storage, redox balance, and cell death pathways (apoptosis and necrosis); their structure is tightly linked to their function, with distinct populations (interfibrillar, subsarcolemmal, perinuclear) positioned within the cardiomyocyte[1][2]. Mitochondrial dysfunction or dysregulation is pivotal in the development and progression of a variety of cardiac diseases including ischemia/reperfusion injury, heart failure, and cardiomyopathy[3][4]. Although mitochondria are essential for cardiac health, they are not a single molecule, receptor, or protein and thus should not be considered a narrow drug target. Rather, numerous therapies act indirectly by influencing mitochondrial function, structure, or signaling[2][3]. Accordingly, "Mitochondria of myocardial cells" is not a specific canonical drug target or receptor and should be considered a structural and functional cell component instead.

Other names

Cardiac mitochondrionmitochondrial compartment of cardiac myocyte

Mitochondrial protective agents prevent permeability transition pore opening - Inhibitors of excessive mitochondrial fission/fusion - Antioxidants reduce ROS generation - Agents that stabilize mitochondrial membrane potential